They have been receiving grants and financial contributions from the universities working on this drug. As the drug moves to phase 1 and beyond, they will need to raise more money as expenses will dramatically increase to run trials. I know the company is very interested in partnering with a big pharma so perhaps that is where they money will come from.
Market Data 
Markets 
AI
